Still leery about animal deaths, FDA lifts a full hold on Friedreich’s ataxia drug — but there’s a big condition

Little Larimar Therapeutics has finally worked its way out of regulatory limbo.

Kind of.

The biotech reported that the FDA has lifted its full clinical …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Still leery about an­i­mal deaths, FDA lifts a full hold on Friedre­ich’s atax­ia drug — but there’s a big con­di­tion